These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3431058)

  • 41. [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
    Lux G
    Fortschr Med; 1996 Aug; 114(22-23):273-5. PubMed ID: 8974961
    [No Abstract]   [Full Text] [Related]  

  • 42. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
    Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
    Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
    [No Abstract]   [Full Text] [Related]  

  • 44. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK
    Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Capsule endoscopy study of gastrointestinal tolerance. Coxibes superior to NSAID plus antacid].
    MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347082
    [No Abstract]   [Full Text] [Related]  

  • 46. [Long-term therapy of peptic ulcer].
    Berndt H
    Z Arztl Fortbild (Jena); 1992 Mar; 86(6):287-90. PubMed ID: 1590008
    [No Abstract]   [Full Text] [Related]  

  • 47. Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradication.
    Treiber G; Walker S; Klotz U
    Arzneimittelforschung; 1997 Jan; 47(1):47-50. PubMed ID: 9037444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. One-week once-daily triple therapy for Helicobacter pylori--a pilot study.
    Chu KM; Kwok KF; Law SY; Wong J
    Hepatogastroenterology; 2000; 47(36):1624-6. PubMed ID: 11149018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of some anticholinergic drugs used in peptic ulcer therapy as based on radiotelemetric studies].
    Chrostowski K; Jeske J
    Pol Tyg Lek; 1971 Aug; 26(33):1265-7. PubMed ID: 4999276
    [No Abstract]   [Full Text] [Related]  

  • 50. [Helium-neon laser and dibunol in gastric and duodenal ulcer].
    Korochkin IM; Deviatkov ND; Poslavskiĭ MV; Aleínikov VS; Mamedli LD
    Sov Med; 1985; (1):31-5. PubMed ID: 3983680
    [No Abstract]   [Full Text] [Related]  

  • 51. [Vitamin B1, B6, PP and C balance in patients with ulcer disease under conditions of complex treatment].
    Litinskaia EV
    Vrach Delo; 1974 Dec; (12):71-5. PubMed ID: 4280658
    [No Abstract]   [Full Text] [Related]  

  • 52. [The influence of low-intensive laser therapy on the aggregation properties of thrombocytes in patients with peptic ulcer].
    Burduli NM; Gutnova SK
    Klin Med (Mosk); 2006; 84(2):61-4. PubMed ID: 16613009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [NSAID-induced ulcers--therapy and prevention].
    Rösch W
    Z Rheumatol; 1995; 54(1):2-8; discussion 9-11. PubMed ID: 7725807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Appraisal of therapeutic agents for peptic ulcer by continuous intragastric pH monitoring].
    Saeki S; Tomofuji Y; Yasuda T; Mitooka H; Onoyama Y; Baba S
    Rinsho Byori; 1984 Oct; 32(10):1076-83. PubMed ID: 6549190
    [No Abstract]   [Full Text] [Related]  

  • 55. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC; Lu SN; Changchien CS
    Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Criteria for subsidizing ulcer therapy].
    Halver B
    Ugeskr Laeger; 1989 Sep; 151(38):2442-4. PubMed ID: 2800022
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of antipeptic effect of medicinal preparations in treatment of ulcer disease].
    Masevich TsG; Gorshkov VA
    Klin Med (Mosk); 1976 Feb; 54(2):51-4. PubMed ID: 1271719
    [No Abstract]   [Full Text] [Related]  

  • 58. [Characteristics of the course of peptic ulcer associated with chronic ischemic heart disease].
    Kushnir LV
    Vrach Delo; 1988 Mar; (3):29-31. PubMed ID: 3394291
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of peptic ulcer using sulpiride].
    Chaud A; Bouroncle JM; Ramírez Del Villar E; Ze-Garra YC
    Rev Clin Esp; 1975 Jan; 136(2):159-64. PubMed ID: 1121592
    [No Abstract]   [Full Text] [Related]  

  • 60. [Local activation of reparative processes in chronic gastroduodenal ulcer].
    Buianov VM; Fokin NS; Perminova GI
    Klin Khir (1962); 1981 Aug; (8):1-4. PubMed ID: 7278010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.